Tempus AI Inc Class A common stock TEM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Tempus Announces Expansion of Collaboration with Takeda to Leverage Multimodal Real-World Datasets and Biological Model Systems in Oncology Research and Development
-
Tempus Launches Beta Version of olivia, its AI-enabled Personal Health Concierge App for Patients
-
Tempus Announces Real World Data Collaboration with BioNTech
-
Tempus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
-
NPJ Precision Oncology Publishes Tempus Study on Validation of its HLA-LOH Investigational Assay
-
Tempus Reports Second Quarter 2024 Results
-
Tempus Next Launches New Algorithm to Close Care Gaps in Guideline-Directed IHC Testing, Starting with HER2
-
Tempus Announces Expanded Data and Sequencing Collaboration with Remix Therapeutics
Trading Information
- Previous Close Price
- $48.96
- Day Range
- $49.59–54.50
- 52-Week Range
- $22.89–77.00
- Bid/Ask
- $52.60 / $53.00
- Market Cap
- $8.17 Bil
- Volume/Avg
- 1.1 Mil / 1.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 14.64
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 2,300
- Website
- https://www.tempus.com
Comparables
Valuation
|
Metric
|
TEM
|
688468
|
301122
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 21.05 | 31.08 |
Price/Book Value | 83.15 | 2.05 | 1.36 |
Price/Sales | 14.64 | 6.16 | 5.73 |
Price/Cash Flow | — | 14.42 | 17.61 |
Price/Earnings
TEM
688468
301122
Financial Strength
|
Metric
|
TEM
|
688468
|
301122
|
|---|---|---|---|
Quick Ratio | 3.35 | 4.71 | 9.53 |
Current Ratio | 3.70 | 5.48 | 11.59 |
Interest Coverage | −12.84 | 111.54 | 7,815.76 |
Quick Ratio
TEM
688468
301122
Profitability
|
Metric
|
TEM
|
688468
|
301122
|
|---|---|---|---|
Return on Assets (Normalized) | −120.01% | 7.46% | 3.62% |
Return on Equity (Normalized) | — | 9.59% | 3.85% |
Return on Invested Capital (Normalized) | — | 7.98% | 3.66% |
Return on Assets
TEM
688468
301122
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock
GEHC
| Qymxrwzf | Xznmt | $41.7 Bil | |||
| Veeva Systems Inc Class A
VEEV
| Wtrnqrgtk | Jwyn | $33.1 Bil | |||
| Pro Medicus Ltd
PMCUF
| — | Jnwffmw | $12.8 Bil | |||
| Solventum Corp
SOLV
| — | Rzwzjf | $11.7 Bil | |||
| Doximity Inc Class A
DOCS
| — | Mxhtwpp | $8.1 Bil | |||
| M3 Inc
MTHRF
| — | Bwhpm | $7.8 Bil | |||
| M3 Inc ADR
MTHRY
| — | Hgxnm | $7.8 Bil | |||
| HealthEquity Inc
HQY
| — | Hhddt | $7.3 Bil | |||
| R1 RCM Inc
RCM
| — | Vkxk | $6.0 Bil |
United States